Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different
ways to stop tumor cells from dividing so they stop growing or die. Giving more than one drug
may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving paclitaxel together with carboplatin
works in treating patients with locally advanced or metastatic collecting duct renal cell
cancer that cannot be removed by surgery.